Skip to main
  1. Stocks
  2. SI-BONE Inc
  3. Forecast
SIBN

SI-BONE Inc (SIBN) Stock Forecast & Price Target

SI-BONE Inc (SIBN) Analyst Ratings

Based on 6 analyst ratings
Strong Buy
Strong Buy 83%
Buy 17%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

SI-BONE is attractive because it continues to deliver strong volume growth, with 3Q26 US procedures up 20% and revenue of $55.7 million rising 14.5% year over year despite a softer orthopedic backdrop. Reaffirmed FY2026 guidance of $231-233 million implies roughly 15-16% growth and about 20% fourth-quarter growth at the midpoint, while gross margin remained high at 79.3% and adjusted EBITDA beat expectations at $3.0 million. The outlook is supported by an expanding surgeon base, improving reimbursement, and the early launch of Onyx and Granite, which together broaden the addressable market and create a path to faster growth and profitability.

Bears say

SI-BONE is facing a bearish setup because the bear case assumes only single-digit revenue growth in the U.S. with margin improvement stalling, suggesting the company may struggle to scale profitably even as it continues commercializing its implant franchise. Competitive launches, iFuse patent expirations, poor sales force execution, unfavorable market dynamics, and slower progress toward profitability all point to erosion in pricing power, growth durability, and operating leverage. The valuation framework also implies limited confidence in the outlook, as the bear case is tied to a 1.5x EV/sales multiple on the 2027E estimate, reinforcing the view that fundamentals remain challenged.

SI-BONE Inc (SIBN) has been analyzed by 6 analysts, with a consensus rating of Strong Buy. 83% of analysts recommend a Strong Buy, 17% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of SI-BONE Inc and is not a guaranteed prediction by Public.com or investment advice.

SI-BONE Inc (SIBN) Analyst Forecast & Price Prediction

Get the latest SI-BONE Inc (SIBN) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in SI-BONE Inc (SIBN)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About SI-BONE Inc (SIBN) Forecast

Analysts have given SI-BONE Inc (SIBN) a Strong Buy based on their latest research and market trends.

According to 6 analysts, SI-BONE Inc (SIBN) has a Strong Buy consensus rating as of Nov 20, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $25, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $25, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

SI-BONE Inc (SIBN)


SI-BONE Inc (SIBN) Analyst Forecast & Price Prediction

Get the latest SI-BONE Inc (SIBN) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in SI-BONE Inc (SIBN)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover SIBN stock data and trends